Global Viral Gastroenteritis Market Overview
Viral Gastroenteritis Market was valued at US$ 6.8 billion in 2024 and is projected to grow at a CAGR of 4.6% to reach US$ 10.2 billion by 2034.
Viral Gastroenteritis Market is a common gastrointestinal illness that affects people all over the world. The lining of the stomach, small intestine, and large intestine is inflamed by viral gastroenteritis, also known as stomach flu. Viral gastroenteritis is caused by a variety of viruses. Norovirus, rotavirus, astrovirus, and enteric adenovirus are among the viruses that cause viral gastroenteritis. The most common viruses that cause this illness are norovirus and rotavirus. Direct contact with the patient, as well as infected water or food, are both ways to spread this disease. The key goal of treatment is to rehydrate the patient by consuming enough water or fluids. Vomiting, nausea, cramps, and muscle ache are all symptoms of viral gastroenteritis.
Impact of Covid-19 pandemic on market
The global public health threat posed by the pandemic of novel coronavirus disease (COVID-19) caused by the Severe Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is enormous. In gastrointestinal cells, traces of SARS-CoV-2 RNA were discovered. Furthermore, the virus's recognised receptor, angiotensin converting enzyme 2 (ACE2), is highly expressed in these cells. This means that the gastrointestinal tract may be infected and serve as a replication site for SARS-CoV-2, but since infection can lead to multiple organ failure, finding a different receptor is a viable option. COVID-19 and related GI conditions have many possible targets that could be used as a therapeutic strategy.
Global Viral Gastroenteritis Market Dynamics
Growth in business operations by emerging and small sized players
The market is growing due to the rising prevalence of gastrointestinal disease around the world, and the research and development in gastroenterology. In addition, rising concerns about the disease's spread among children and the urgent need to treat viral gastroenteritis are driving market development. Manufacturers' introduction of novel products and an expanding patient pool are expected to drive the gastrointestinal infection testing market forward during the forecast period. In addition, there is a growing need for new medications to treat the disease.
Global Viral Gastroenteritis Market Segmentation
The Viral Gastroenteritis market is segmented based on type, drugs, diagnosis, end-use, and region.
On the basis of type, the viral gastroenteritis market is segmented into Rotavirus and Norovirus. Based on drugs, the target market is segmented into Antacids, Antibiotics, Laxatives and Antimobility agents. On the basis of diagnosis, the market is segmented into Rapid stool tests and Physical examination. On the basis of end-use, the target market is segmented into Hospitals, Diagnostic centers, Clinics and Others.
Regional Insights:
On region the Viral Gastroenteritis market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to lead the market in the upcoming forecast era. This is mainly attributed because of the increasing prevalence of viral gastroenteritis in the U.S., especially among children. The second-largest market for viral gastroenteritis is Europe. Rotavirus is the most common cause of serious gastroenteritis in children under the age of five years in Asia Pacific. Increased demand for rapid diagnostic tests for gastrointestinal diseases and increased knowledge of available treatment options for viral gastroenteritis are driving the market in Asia Pacific.
Viral Gastroenteritis Market Report Scope:
|
Attribute |
Details |
|
Market Size 2024 |
US$ 6.8 billion |
|
Projected Market Size 2034 |
US$ 10.2 billion |
|
CAGR Growth Rate |
4.6 % |
|
Market Segmentation
|
By Type -Rotavirus and Norovirus
By Drugs -Antacids, Antibiotics, Laxatives Anti mobility Agents
By Diagnosis- Rapid Stool Test and Physical Examination
By End-Use- Hospital, Diagnostic Centers, Clinics and Others
|
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global viral gastroenteritis market report based on type, drugs, diagnosis, end-use, and region.
Viral Gastroenteritis Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Global Viral Gastroenteritis Market Key Players
The key players operating in the viral gastroenteritis market includes Abbott, Valeant Pharmaceuticals International Inc. Janssen Global Services, LLC, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc., Bayer AG, AstraZeneca and Sanofi.
Global Viral Gastroenteritis Market Key Issues Addressed
- In April 2023, Researchers at Washington University School of Medicine in St. Louis came up with a novel method to create a vaccine against norovirus by building on the extremely successful rotavirus vaccines, which targets the rotavirus a different virus that also causes diarrhoea. The novel dual vaccination, which combines the major two viruses that cause diarrhoea, produces antibodies that protect against rotavirus and norovirus infections.
Global Viral Gastroenteritis Market Company Profile
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Valeant Pharmaceuticals International Inc.
- Janssen Global Services
- LLC
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline Plc.
- Bayer AG
- AstraZeneca
- Sanofi
“*” marked represents similar segmentation in other categories in the respective section
Global Viral Gastroenteritis Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Viral Gastroenteritis Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Drugs
- Market Snippet, By Diagnosis
- Market Snippet, By End-User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Rotavirus
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Norovirus
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Drugs, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Antacids
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Antibiotics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Laxatives
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Antimobility agents
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By Diagnosis, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Rapid Stool tests
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Physical examination
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation, By End-User, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Diagnostic centers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Clinics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
-
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Technology, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Patients, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Valeant Pharmaceuticals International Inc.
- Janssen Global Services
- LLC
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline Plc.
- Bayer AG
- AstraZeneca
- Sanofi
The Last Word
- Future Impact
- About Us
- Contact
Global Viral Gastroenteritis Market Highlights
FAQs
The viral gastroenteritis market is segmented based on type, drug, diagnosis end-use, and region.
The market is growing due to the rising prevalence of gastrointestinal disease around the world, and the research and development in gastroenterology.
North America is expected to lead the market in the upcoming forecast era. This is mainly attributed because of the increasing prevalence of viral gastroenteritis in the United States, especially among children.
The numerous key players are focusing on products improvement and new product launches. Abbott and Janssen Global Services are some of the major key players in the market.